By Kim Richters

Roche Holding AG (RO.EB) said Monday that it has extended the offer period for its planned takeover of biotechnology company Spark Therapeutics Inc. (ONCE) to Dec. 16.

Swiss pharmaceutical company Roche said the offer was extended to provide additional time for the U.S. Federal Trade Commission and the U.K. Competition and Markets Authority to complete their reviews of the pending acquisition.

The period for Roche's offer of $114.50 per share has been extended several times and was set to expire on Dec. 10.

As of Dec. 6, around 14.9% of Spark's outstanding shares had been tendered, according to Roche.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

December 09, 2019 02:01 ET (07:01 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Onconetix (NASDAQ:ONCE)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Onconetix.
Onconetix (NASDAQ:ONCE)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Onconetix.